Latest filing published 01 Oct 2026 for Helus Pharma Inc..
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Eric H. L. So span 2 companies, the busiest being Cybin Inc. and Helus Pharma Inc. In total, 4 filings cover trades dated from 1 September 2026 to 30 September 2026.
Every open-market trade on record is a purchase: 3 purchases worth €3.1M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant.
Half of the purchases are above €1.0M and half below. Measured against the company's value, the median purchase equals 0.15% of market capitalisation, across 3 purchases where it is known. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The latest filing, published on 1 October 2026, reports a share grant in Helus Pharma Inc. The last purchase on record was published on 11 September 2026, which is 45 days ago. Filings reach the SEDI feed a median of 5 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations